Mirum’s CTEXLI Tablets FDA-Approved for Cerebrotendinous Xanthomatosis

Read more

FDA Accepts BMS’ SBLAs for Opdivo + Yervoy in MSI-High, MMR-D Cancer

Read more

EMA Validates Gilead’s Application for Twice-Yearly Lenacapavir as HIV Prevention

Read more

Teva and Alvotech Launch SELARSDI Injection in the U.S.

Read more

Boehringer’s Zongertinib Gets U.S. FDA Priority Review for HER2-Mutant Advanced NSCLC

Read more

FDA Grants ImmunityBio Approval to Supply Recombinant BCG (rBCG) Amid TICE BCG Shortage

Read more

Rznomics Inc. Liver Cancer Drug Receives Fast Track Designation

Read more

FDA Accepts Dupixent sBLA for Bullous Pemphigoid Treatment under Priority Review

Read more

FDA Accepts Gilead’s NDA for Twice-Yearly Lenacapavir for HIV Prevention

Read more

Biogen and Stoke Therapeutics Partner to Develop Zorevunersen for Dravet Syndrome Treatment

Read more